K123354

Substantially Equivalent

REVITIVE IX

Applicant: Actegy , Ltd.
Product code: IPF
Advisory panel: Physical Medicine
Date received: 2012-10-31
Decision date: 2013-06-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Washington, DC, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.